Evans R A
Aust N Z J Med. 1977 Jun;7(3):259-61. doi: 10.1111/j.1445-5994.1977.tb03682.x.
Nine patients with painful Paget's disease of bone were treated for 200 days with a drug combination designed to elevated plasma calcium, hence stimulating the production of endogenous calcitoning and suppressing that of parathyroid hormone. This combination was oral calcium, a thiazide diuretic, a low phosphorus diet and aluminium hydroxide. Eight of the nine patients experienced sustained pain relief after 20--70 days. The mean plasma alkaline phosphatase (expressed as a percentage of the pre-treatment level) commenced to fall after 30 days of treatment and at 120 days was 58% of the pre-treatment level; this fall was sustained at 200 days. There was a mean rise of 0-08 mmol/l in plasma calcium; there was no significant change in plasma inorganic phosphorus or plasma creatinine. In view of the extremely low cost of this drug combination and its lack of side-effects, it is suggested it be considered as a treatment for Paget's disease of bone.
9例患有疼痛性骨佩吉特病的患者接受了一种旨在提高血浆钙水平的联合药物治疗200天,从而刺激内源性降钙素的产生并抑制甲状旁腺激素的产生。这种联合用药包括口服钙、噻嗪类利尿剂、低磷饮食和氢氧化铝。9例患者中有8例在20至70天后疼痛持续缓解。血浆碱性磷酸酶(以治疗前水平的百分比表示)在治疗30天后开始下降,在120天时为治疗前水平的58%;这种下降在200天时持续存在。血浆钙平均升高0.08 mmol/l;血浆无机磷或血浆肌酐无显著变化。鉴于这种联合药物成本极低且无副作用,建议将其视为骨佩吉特病的一种治疗方法。